PRESS RELEASE published on 01/18/2024 at 17:00, 2 years 8 months ago Metrodora Foundation Announces New Scientific Advisory Board The Metrodora Foundation has announced the formation of a new Scientific Advisory Board (SAB) comprised of leading experts in life sciences, clinical research, technology, and industry. The SAB will provide strategic guidance to accelerate critical research for patients living with chronic, multisystem disorders such as Long-Covid, ME/CFS, POTS, and others. The Foundation aims to catalyze scientific collaboration and discovery to find new diagnostics, treatments, and cures for these complex conditions. The esteemed group of scientific thought leaders collaborating with Metrodora will work towards understanding the biological drivers of these underserved conditions and improving patient outcomes. Metrodora Foundation Scientific Advisory Board Chronic Multisystem Disorders Patient Outcomes Scientific Collaboration
PRESS RELEASE published on 01/05/2024 at 15:00, 2 years 8 months ago Metrodora Institute Announces New Chief Scientific Officer Metrodora Institute, a leading multispecialty healthcare institute, announces the hiring of Rohit Gupta, a nationally recognized scientist, biobank, and data expert, as its new Chief Scientific Officer and Head of R&D. Gupta's extensive experience and expertise in leading research enterprises and developing innovative medical technology make him a valuable addition to the institute. His vision and leadership will accelerate Metrodora's goals of developing and adopting new solutions to improve the lives of the patients they serve. Located in Salt Lake City, Utah, Metrodora Institute was founded in 2021 with the vision of reimagining care for patients with complex multisystem disorders, treating neurological, gastrointestinal, immunological, autoimmune, pain, and metabolic disorders. Metrodora Institute Rohit Gupta Chief Scientific Officer Biobank Multispecialty Healthcare
PRESS RELEASE published on 12/13/2023 at 15:00, 2 years 9 months ago Metrodora Institute Appoints Dr. Brent P. Goodman, MD, as Chief Medical Officer
Published on 09/23/2026 at 22:00, 7 hours 51 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 11 hours 26 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 14 hours 9 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 15 hours 20 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 15 hours 21 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/24/2026 at 05:08, 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3G and 3H
Published on 09/24/2026 at 03:24, 2 hours 26 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Notice of Annual General Meeting
Published on 09/23/2026 at 23:00, 6 hours 51 minutes ago Correction d’un communiqué du 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 23:00, 6 hours 51 minutes ago Correction of a release from 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND THE PARTIAL EARLY REDEMPTION OF BONDS REDEEMABLE IN SHARES
Published on 09/23/2026 at 19:51, 10 hours ago LIGHTON: LightOn renouvelle son financement obligataire auprès des mêmes partenaires financiers pour un montant nominal maximum de 4 millions d’euros, et étend ainsi son horizon de trésorerie
Published on 09/23/2026 at 19:46, 10 hours 5 minutes ago SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 10 hours 37 minutes ago Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 19:14, 10 hours 37 minutes ago Performance robuste des Investissements, poursuite du déploiement de la stratégie